MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/microorganisms12040705

Медицинская библиотека · Microorganisms · 2024

Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy.

Royo-Cebrecos Cristina, Laporte-Amargós Júlia, Peña Marta, Ruiz-Camps Isabel, Garcia-Vidal Carolina, Abdala Edson, Oltolini Chiara, Akova Murat, Montejo Miguel, Mikulska Malgorzata, Martín-Dávila Pilar, Herrera Fabián, Gasch Oriol, Drgona Lubos, Morales Hugo Manuel Paz, Brunel Anne-Sophie, García Estefanía, Isler Burcu, Kern Winfried V, Palacios-Baena Zaira R, de la Calle Guillermo Maestr, Montero Maria Milagro, Kanj Souha S, Sipahi Oguz R, Calik Sebnem, Márquez-Gómez Ignacio, Marin Jorge I, Gomes Marisa Z R, Hemmatii Philipp, Araos Rafael, Peghin Maddalena, Del Pozo Jose L, Yáñez Lucrecia, Tilley Robert, Manzur Adriana, Novo Andrés, Carratalà Jordi, Gudiol Carlota, IRONIC Study Group

СтатьяПеревод в очереди

Аннотация

This large, multicenter, retrospective cohort study including onco-hematological neutropenic patients with Pseudomonas aeruginosa bloodstream infection (PABSI) found that among 1213 episodes, 411 (33%) presented with septic shock. The presence of solid tumors (33.3% vs. 20.2%, p < 0.001), a high-risk Multinational Association for Supportive Care in Cancer (MASCC) index score (92.6% vs. 57.4%; p < 0.001), pneumonia (38% vs. 19.2% p < 0.001), and infection due to multidrug-resistant P. aeruginosa (MDRPA) (33.8% vs. 21.1%, p < 0.001) were statistically significantly higher in patients with septic shock compared to those without. Patients with septic shock were more likely to receive inadequate empirical antibiotic therapy (IEAT) (21.7% vs. 16.2%, p = 0.020) and to present poorer outcomes, including a need for ICU admission (74% vs. 10.5%; p < 0.001), mechanical ventilation (49.1% vs. 5.6%; p < 0.001), and higher 7-day and 30-day case fatality rates (58.2% vs. 12%, p < 0.001, and 74% vs. 23.1%, p < 0.001, respectively). Risk factors for 30-day case fatality rate in patients with septic shock were orotracheal intubation, IEAT, infection due to MDRPA, and persistent PABSI. Therapy with granulocyte colony-stimulating factor and BSI from the urinary tract were associated with improved survival. Carbapenems were the most frequent IEAT in patients with septic shock, and the use of empirical combination therapy showed a tendency towards improved survival. Our findings emphasize the need for tailored management strategies in this high-risk population.

Для цитирования: Royo-Cebrecos Cristina, Laporte-Amargós Júlia, Peña Marta, Ruiz-Camps Isabel, Garcia-Vidal Carolina, Abdala Edson, Oltolini Chiara, Akova Murat, Montejo Miguel, Mikulska Malgorzata, Martín-Dávila Pilar, Herrera Fabián, Gasch Oriol, Drgona Lubos, Morales Hugo Manuel Paz, Brunel Anne-Sophie, García Estefanía, Isler Burcu, Kern Winfried V, Palacios-Baena Zaira R, de la Calle Guillermo Maestr, Montero Maria Milagro, Kanj Souha S, Sipahi Oguz R, Calik Sebnem, Márquez-Gómez Ignacio, Marin Jorge I, Gomes Marisa Z R, Hemmatii Philipp, Araos Rafael, Peghin Maddalena, Del Pozo Jose L, Yáñez Lucrecia, Tilley Robert, Manzur Adriana, Novo Andrés, Carratalà Jordi, Gudiol Carlota, IRONIC Study Group. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy.. Microorganisms. 2024. DOI: 10.3390/microorganisms12040705.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.